WebApr 6, 2024 · What happened to Dice Therapeutics’s price movement after its last earnings report? Dice Therapeutics reported an EPS of -$0.51 in its last earnings report, missing expectations of -$0.484. Following the earnings report the stock price went up 6.804%. WebFind the latest DICE Therapeutics, Inc. (DICE) stock quote, history, news and other vital information to help you with your stock trading and investing. Discover historical prices for DICE stock on Yahoo Finance. View daily, weekly or … Find the latest DICE Therapeutics, Inc. (DICE) stock discussion in Yahoo … DICE Therapeutics, Inc. (DICE) NasdaqGM - NasdaqGM Real Time Price. Currency … Find out all the key statistics for DICE Therapeutics, Inc. (DICE), including … Holder Shares Date Reported % Out Value; Price (T.Rowe) New Horizons Fund: … Get the detailed quarterly/annual income statement for DICE Therapeutics, Inc. … Interactive Chart for DICE Therapeutics, Inc. (DICE), analyze all the data with a … See DICE Therapeutics, Inc. (DICE) stock analyst estimates, including earnings … DICE Therapeutics, Inc. 400 East Jamie Court Suite 300 South San Francisco, … See DICE Therapeutics, Inc. (DICE) Environment, Social and Governance …
Dice Therapeutics (DICE) Stock Price & Analysis - TipRanks
WebStock analysis for DICE Therapeutics Inc (DICE:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. WebDice Therapeutics has raised a total of $532.4M in funding over 7 rounds. Their latest funding was raised on Oct 17, 2024 from a Post-IPO Equity round. ... IPO Share Price $17.00; IPO Date Sep 14, 2024; Stock chart by . Investors. Edit Investors Section. Number of Lead Investors 4. northern high school volleyball
DICE THERAPEUTICS
WebWe design and develop innovative oral medicines against biologically validated targets in immunology for the treatment of chronic autoimmune and inflammatory diseases. We are … WebMar 8, 2024 · The DICE stock price is -61.31% off its 52-week. DICE Therapeutics Inc. (NASDAQ:DICE) has seen 1.6 million shares traded in the last trading session. The company, currently valued at $1.33B, closed the last trade at $28.51 per share which meant it lost -$2.96 on the day or -9.41% during that session. The DICE stock price is -61.31% … WebOct 11, 2024 · Clinical proof-of-concept in psoriasis patients achieved with a mean percentage reduction in PASI from baseline at 4 weeks of 43.7% in the high dose group compared to 13.3% in the placebo group ... how to rocket jump valorant